NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.
Status:
Completed
Trial end date:
2018-05-07
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of rivastigmine patch with 1-step titration on cognitive function
measured as change from baseline to week 24 in the total score of Mini-Mental State
Examination (MMSE) in mild to moderate Alzheimer's disease (AD) patients who failed to
benefit from other cholinesterase inhibitors (ChEIs).